Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial.

Esquivel-Moynelo Idelsis; Perez-Escribano Jesus; Duncan-Robert Yaquelin; Vazquez-Blonquist Dania; Bequet-Romero Monica; Baez-Rodriguez Lisandra; Castro-Rios Jesus; Cobas Cervantes Lisbeth; Page-Calvet Ernesto; Travieso-Perez Saily; Martinez-Suarez Claudia; Campa-Legra Ivan; Fernandez-Masso Julio Raul; Camacho-Rodriguez Hamlet; Diaz-Galvez Marisol; Sin-Mayor Adriana; Garcia-Sanchez Maura; Martinez-Martin Sara Maria; Alonso-Valdes Marel; Hernandez-Bernal Francisco; Nodarse-Cuni Hugo; Bello-Garcia Dianela; Beato-Canfuk Abrahan; Vizcaino-Cesar Mary Tania; Guillen-Nieto Gerardo; Muzio-Gonzalez Verena; Bello-Rivero Iraldo.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20164251